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 Low-sodium diets stimulate aldosterone 
production through activation of the 
renin – angiotensin – aldosterone axis. Al-
dosterone given exogenously stimulates 
urinary potassium excretion. 1 Yet pa-
tients (or animals) on low-salt diets do 
not typically develop potassium wasting 
and hypokalemia. High-potassium diets 
increase adrenal production of aldoster-
one. Despite the well-known stimulation 
of sodium reabsorption by aldosterone, 
these patients (or animals) do not typically 
become hypervolemic and hypertensive. 
Mechanisms underlying this physiologi-
cal conundrum have been proposed and 
investigated ( Figure 1a and b ). Yue  et al. 2 
propose another potential mechanism that 
may allow for potassium preservation in 
the volume-depleted patient ( Figure 1c ). 
 ROMK1 channels mediate basal potas-
sium secretion in the distal nephron. 
However, exogenously administered 
aldosterone does not appear to aff ect the 
channel density of either ROMK1 or fl ow-
stimulated BK channels in the cortical 
collecting ducts (CCDs) of rats. 3 An 
increase in potassium secretion without 
an increase in the activity of potassium 
channels is probably secondary to the 
well-known robust stimulation of the epi-
thelial sodium channel that increases the 
driving force for distal tubular potassium 
secretion. In contrast, high-potassium 
diets strongly stimulate ROMK channel 
activity. There are conflicting studies 
regarding the eff ect of a low-sodium diet 
on potassium secretion. Engbretson and 
Stoner found a diff erence in potassium 
secretion in  in vitro microperfused CCDs 
of rabbits on a low-salt diet versus rabbits 
on a high-salt diet. 4 However, Estilo  et al. , 
using similar methodology, found no dif-
ference in baseline potassium secretion in 
the CCDs of rabbits on a low-salt diet ver-
sus those on a high-salt diet. 5 Importantly, 
Engbretson and Stoner used a moderately 
high-potassium diet and then supple-
mented that with liquid KCl. Th us they 
were essentially modeling the well-known 
stimulation of potassium secretion by a 
high-potassium diet. Th e study by Estilo 
 et al. , when combined with the study by 
Palmer and Frindt, 3 indicates that there 
may be some potassium preservation 
pathway that compensates for aldoster-
one ’ s eff ect of increasing the driving force 
for potassium secretion in a low-salt envi-
ronment. Th is results in the appropriate 
physiological response of unchanged 
potassium excretion in the face of a low-
salt, normal-potassium diet. Th ese results 
suggested that there was an aldosterone-
independent kaliuretic factor that was 
stimulated by a high-potassium diet. 
 Th e development of potential mecha-
nistic explanations of this phenomenon 
was aided by the molecular characteriza-
tion of pseudohypoaldosteronism type II 
(PHAII), or familial hyperkalemic hyper-
tension. PHAII is the monogenic disorder 
of hypertension and hyperkalemia that 
results from mutations of the WNK (with 
no lysine) kinases WNK1 and WNK4. 6 
Multiple studies indicate that the hyper-
tension of this disorder is largely mediated 
by hyperactivity of the sodium chloride 
cotransporter (NCC). An in-depth review 
of the mechanisms of WNK ’ s eff ects on 
NCC is beyond the scope of this Com-
mentary on potassium secretion and has 
been undertaken many times recently. 
Suffi  ce it to say that WNK1 is stimulatory 
to NCC and that WNK4 may be either 
inhibitory or stimulatory depending on 
which system it is assessed in, and / or 
physiological conditions. WNK1 and 
WNK4 both phosphorylate and activate 
the kinase Ste20-related proline / alanine-
rich kinase (SPAK), which activates and 
phosphorylates NCC. Notably, a truncated 
kidney-specific WNK1 (KS-WNK1) 
seems to inhibit WNK1 ’ s eff ect on NCC. 
 The hyperkalemia associated with 
PHAII provides insight into the physiol-
ogy of distal tubular potassium secretion. 
The full-length isoform of WNK1 
(L-WNK1) decreases the cell-surface 
expression of ROMK1 channels in the 
 Xenopus oocyte expression system. KS-
WNK1 appears to inhibit this process, 
resulting in increased ROMK1 channel 
on the cell surface. 7 Thus a gain-of-
 function mutation of WNK1 would result 
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in impairment of potassium secretion 
and hyperkalemia. It has also been pro-
posed that the hyperactivity of NCC 
resulting in greatly decreased sodium 
delivery to the connecting tubule (CNT) 
and CCD is sufficient to explain the 
impairment in potassium secretion in 
PHAII. Th ese investigations concerning 
the pathophysiology of this process have 
signifi cant implications for the physiol-
ogy of potassium handling in the distal 
tubule. In fact, high-potassium diets 
induce increased expression of the KS-
WNK1 isoform relative to the L-WNK1 
isoform. Th is would result in increased 
ROMK surface expression and secretion 
of potassium. Th is process would pre-
sumably be inactive with a low-salt and 
normal-potassium diet. Th erefore, the 
balance of L-WNK1 and KS-WNK1 has 
been suggested as the critical switch 
allowing for greatly increased potassium 
secretion in the face of a high-potassium, 
high-aldosterone state while sparing 
potassium in a low-salt, high-aldosterone 
state ( Figure 1b ). Alternatively, a body of 
evidence has been amassed implicating 
aldosterone as a key regulator of NCC. 8 
Th is has led to the hypothesis that the 
strong upregulation of NCC induced by 
a low-salt diet results in greatly decreased 
sodium delivery to the CNT and CCD 
and thus decreased potassium secretion 
( Figure 1a ). Th e relatively low-fl ow state 
would also keep BK channels inactive. 
With a high-potassium, normal-sodium 
diet, sodium delivery would be suffi  cient 
to result in robust potassium secretion in 
the presence of aldosterone. Both of these 
potential mechanisms of potassium pres-
ervation in the face of a hypovolemic, 
high-aldosterone state would presumably 
be opposed by SGK1-dependent stimula-
tion of ROMK1 (probably by inhibition 
of WNK4-mediated endocytosis of 
ROMK1) and the epithelial sodium 
channel. 
 On the basis of their new study 2 and 
their previous studies, Yue  et al. add an 
additional hypothesis to help explain this 
physiological conundrum. Th ey propose 
that angiotensin II is a major mediator of 
the disparate eff ects on potassium secre-
tion produced by these two different 
physiological milieus (high-potassium 
diet and low-sodium diet) that both 
 stimulate aldosterone. In this scenario, 
angiotensin II is activated under condi-
tions of a low-salt diet or  volume deple-
tion and acts as an inhibitor of ROMK1 
channels ( Figure 1c ). A high-potassium 
diet suppresses angiotensin II, resulting in 
attenuation of the inhibition of ROMK1 
and in stimulation of robust potassium 
secretion. Studies have indicated that 
luminal angiotensin II inhibits potassium 
secretion in the late distal tubule 9 and that 
angiotensin II inhibits ROMK1 with a 
low-potassium diet. 10 Yue  et al. 2 now 
present evidence that angiotensin II 
inhibits ROMK1 through stimulation of 
the protein tyrosine kinase c-Src. c-Src 
then inhibits ROMK1 surface expression 
by two diff erent mechanisms: direct phos-
phorylation of ROMK1 at residue Y337, 
resulting in endocytosis of ROMK, and 
disruption of SGK1 ’ s inhibitory eff ect on 
WNK4, allowing WNK4-mediated endo-
cytosis of ROMK1. As SGK1 is an aldos-
terone-induced protein, angiotensin II 
could be acting to attenuate aldosterone ’ s 
eff ect on potassium secretion with low-
salt diet. Th is could explain aldosterone ’ s 
lack of stimulation of potassium secretion 
or ROMK in the CNT and CCD despite 
SGK1 ’ s  stimulation of ROMK. 
 In support of the molecular biology 
data, the authors present animal data 
demonstrating that  angio tensin II reduces 
potassium channel acti vity in the CCD 
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 Figure 1  |  Potential mechanisms of potassium preservation in a volume-depleted state. ( a ) Aldo and Ang are secreted in a volume-depleted 
state, resulting in stimulation of NCC and a decrease in sodium delivery to the CNT/CCD.  ( b ) Under conditions of a normal-potassium diet, WNK1 is 
preferentially expressed over KS-WNK1, resulting in unopposed inhibition of ROMK1. A high-potassium diet would result in preferential expression 
of KS-WNK1 and opposition of WNK1 ’ s inhibition of ROMK1. ( c ) Ang secretion results in stimulation of protein tyrosine kinase (such as c-SRC) and 
suppression of ROMK1 by two mechanisms. c-SRC directly phosphorylates ROMK1 and also opposes the effect of serum-and-glucocorticoid-inducible 
kinase 1 (SGK1) on WNK4. This results in release of WNK4 ’ s inhibitory effect on ROMK1. Note: the MR receptor is depicted here as a cell membrane 
receptor as opposed to its true intracellular location for ease of presentation. Aldo, aldosterone; Ang, angiotensin II; AR, angiotensin II receptor, 
type 1; CCD, cortical collecting duct; CNT, connecting tubule; DCT, distal convoluted tubule; MR, mineralocorticoid receptor; NCC, sodium chloride 
cotransporter; SGK, serum- and glucocorticoid-inducible kinase; WNK, with-no-lysine kinase.   
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with a low-sodium diet. Patch clamp 
experiments on split-open CCDs of 
 animals fed a low-sodium diet for 7 days 
showed a robust stimulation of ROMK 
channel activity by angiotensin. In a pre-
vious study, Wei  et al. demonstrated that 
angiotensin II inhibits ROMK channel 
activity under conditions of a low-potas-
sium diet but not under conditions of a 
normal-potassium diet. 10 So, apparently, 
not only does a high-potassium diet sup-
press angiotensin II, but it also may make 
ROMK channels resistant to the eff ects of 
angiotensin II. However, if angiotensin 
II-induced c-Src inhibited the eff ect of SGK 
on WNK4 in the distal convoluted tubule, 
then that would result in inhibition of NCC 
function (which clearly does not happen 
with increased angiotensin II and aldoster-
one). Th erefore, this theory requires that 
c-Src is acting on the SGK1 – WNK4 inter-
action only in the CNT and CCD and not 
in the distal convoluted tubule. Th is type of 
cell-specifi c eff ect is certainly possible but 
has yet to be proven.  
 Th e authors astutely point out that these 
theories do not exclude each other, and in 
fact it is quite likely that multiple factors 
play a role in this phenomenon. Another 
potential factor to consider here is the 
temporal nature of these eff ects. In this 
study the authors looked at acute eff ects 
of angiotensin (within minutes) in both 
their animal and their cell-culture experi-
ments. Aldosterone probably upregulates 
NCC over periods of days (although 
shorter-term effects of aldosterone on 
NCC have not been studied). So it may be 
that the angiotensin II eff ect is responsible 
for acute preservation of potassium in the 
face of a low-salt diet or volume depletion 
and NCC upregulation by aldosterone is 
responsible for chronic preservation of 
potassium. It is unknown how quickly the 
diet-induced changes in WNK1 isoforms 
occur, but they could play an acute or 
chronic role. Th e example of Gitelman ’ s 
syndrome, in which patients have signifi -
cant potassium wasting despite chronic 
angiotensin II / aldosterone stimulation, 
would argue that decreased sodium deliv-
ery is the primary chronic preservation 
mechanism. Because these patients lack 
fully functional NCC, they are unable to 
increase NCC activity. Th erefore, sodium 
delivery to the CNT and CCD cannot be 
decreased, and they develop potassium 
wasting despite angiotensin. Nonetheless, 
acute preservation of potassium (less than 
72  h) is also of great import, and all of 
these pathways for potassium preserva-
tion are likely to be physiologically 
 important. 
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 Nanocrystals seed calcification 
in more ways than one 
 Diane  Proudfoot 1 and  Catherine M.  Shanahan 1 
 Although much progress has been made in the past five years in 
understanding the mechanisms leading to accelerated vascular 
calcification in patients with chronic kidney disease, it remains unclear 
how an environment high in phosphate can impinge so significantly on 
the calcification process. The study by Sage  et al. highlights an important 
and novel role for calcium phosphate nanocrystals, produced in a high-
phosphate environment, in rapidly driving calcification of vascular smooth 
muscle cells via enhanced production of bone morphogenetic protein-2. 
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 ELEVATED PHOSPHATE PROMOTES 
VASCULAR SMOOTH MUSCLE CELL 
CALCIFICATION 
 Vascular calcifi cation in patients with 
chronic kidney disease (CKD) is a prev-
alent condition that contributes to a high 
incidence of cardiovascular mortality. 
Clinical studies have demonstrated that 
elevated serum levels of phosphate (P) 
correlate with calcifi cation and mortal-
ity, and hence there have been increased 
eff orts in recent years to try and estab-
lish the mechanisms whereby elevated P 
acts to promote vascular calcifi cation. 
 Although vascular calcifi cation in CKD 
was once considered an end-stage  ‘ passive ’ 
process of precipitation of calcium phos-
phate (Ca / P) in the vessel wall, evidence 
